| Dataset | w1a_vs_wt_vs_wt.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp_repos |
| Phenotype | w1a_vs_wt.cls#ago1w1a_versus_ago1gfp_repos |
| Upregulated in class | ago1gfp |
| GeneSet | KEGG_CHEMOKINE_SIGNALING_PATHWAY |
| Enrichment Score (ES) | -0.2702805 |
| Normalized Enrichment Score (NES) | -1.1500894 |
| Nominal p-value | 0.09558824 |
| FDR q-value | 0.58788925 |
| FWER p-Value | 1.0 |

| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | DOCK2 | NA | DOCK2 Entrez,  Source | dedicator of cytokinesis 2 | 203 | 4.074 | 0.0157 | No |
| 2 | CCL26 | NA | CCL26 Entrez,  Source | chemokine (C-C motif) ligand 26 | 628 | 2.872 | 0.0111 | No |
| 3 | SHC3 | NA | SHC3 Entrez,  Source | SHC (Src homology 2 domain containing) transforming protein 3 | 635 | 2.856 | 0.0298 | No |
| 4 | PIK3CA | NA | PIK3CA Entrez,  Source | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 749 | 2.649 | 0.0411 | No |
| 5 | IKBKG | NA | IKBKG Entrez,  Source | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 818 | 2.562 | 0.0543 | No |
| 6 | CXCL16 | NA | CXCL16 Entrez,  Source | chemokine (C-X-C motif) ligand 16 | 870 | 2.489 | 0.0680 | No |
| 7 | CCL28 | NA | CCL28 Entrez,  Source | chemokine (C-C motif) ligand 28 | 891 | 2.470 | 0.0834 | No |
| 8 | GRK4 | NA | GRK4 Entrez,  Source | G protein-coupled receptor kinase 4 | 940 | 2.414 | 0.0968 | No |
| 9 | GNB4 | NA | GNB4 Entrez,  Source | guanine nucleotide binding protein (G protein), beta polypeptide 4 | 1058 | 2.265 | 0.1053 | No |
| 10 | CXCL10 | NA | CXCL10 Entrez,  Source | chemokine (C-X-C motif) ligand 10 | 1224 | 2.107 | 0.1101 | No |
| 11 | IKBKB | NA | IKBKB Entrez,  Source | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 1288 | 2.052 | 0.1202 | No |
| 12 | CXCL11 | NA | CXCL11 Entrez,  Source | chemokine (C-X-C motif) ligand 11 | 1398 | 1.950 | 0.1271 | No |
| 13 | PIK3R3 | NA | PIK3R3 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) | 1410 | 1.946 | 0.1394 | No |
| 14 | CXCR4 | NA | CXCR4 Entrez,  Source | chemokine (C-X-C motif) receptor 4 | 1561 | 1.836 | 0.1432 | No |
| 15 | STAT1 | NA | STAT1 Entrez,  Source | signal transducer and activator of transcription 1, 91kDa | 2025 | 1.543 | 0.1275 | No |
| 16 | GNG13 | NA | GNG13 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 13 | 2088 | 1.504 | 0.1341 | No |
| 17 | PIK3R1 | NA | PIK3R1 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) | 2108 | 1.493 | 0.1429 | No |
| 18 | PLCB4 | NA | PLCB4 Entrez,  Source | phospholipase C, beta 4 | 2273 | 1.422 | 0.1432 | No |
| 19 | CXCL2 | NA | CXCL2 Entrez,  Source | chemokine (C-X-C motif) ligand 2 | 2490 | 1.328 | 0.1399 | No |
| 20 | VAV1 | NA | VAV1 Entrez,  Source | vav 1 oncogene | 2559 | 1.297 | 0.1447 | No |
| 21 | GNAI1 | NA | GNAI1 Entrez,  Source | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | 2654 | 1.262 | 0.1479 | No |
| 22 | ARRB2 | NA | ARRB2 Entrez,  Source | arrestin, beta 2 | 2737 | 1.232 | 0.1515 | No |
| 23 | SHC2 | NA | SHC2 Entrez,  Source | SHC (Src homology 2 domain containing) transforming protein 2 | 2820 | 1.207 | 0.1549 | No |
| 24 | SOS2 | NA | SOS2 Entrez,  Source | son of sevenless homolog 2 (Drosophila) | 2927 | 1.172 | 0.1568 | No |
| 25 | STAT2 | NA | STAT2 Entrez,  Source | signal transducer and activator of transcription 2, 113kDa | 2947 | 1.166 | 0.1635 | No |
| 26 | CCR7 | NA | CCR7 Entrez,  Source | chemokine (C-C motif) receptor 7 | 3093 | 1.118 | 0.1628 | No |
| 27 | SHC4 | NA | SHC4 Entrez,  Source | SHC (Src homology 2 domain containing) family, member 4 | 3135 | 1.107 | 0.1679 | No |
| 28 | SOS1 | NA | SOS1 Entrez,  Source | son of sevenless homolog 1 (Drosophila) | 3824 | 0.911 | 0.1353 | No |
| 29 | NCF1 | NA | NCF1 Entrez,  Source | neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1) | 3878 | 0.897 | 0.1383 | No |
| 30 | JAK2 | NA | JAK2 Entrez,  Source | Janus kinase 2 (a protein tyrosine kinase) | 4058 | 0.852 | 0.1339 | No |
| 31 | CCR6 | NA | CCR6 Entrez,  Source | chemokine (C-C motif) receptor 6 | 4101 | 0.842 | 0.1372 | No |
| 32 | BCAR1 | NA | BCAR1 Entrez,  Source | breast cancer anti-estrogen resistance 1 | 4149 | 0.829 | 0.1401 | No |
| 33 | CDC42 | NA | CDC42 Entrez,  Source | cell division cycle 42 (GTP binding protein, 25kDa) | 4324 | 0.788 | 0.1355 | No |
| 34 | CXCL14 | NA | CXCL14 Entrez,  Source | chemokine (C-X-C motif) ligand 14 | 4525 | 0.743 | 0.1293 | No |
| 35 | CCL8 | NA | CCL8 Entrez,  Source | chemokine (C-C motif) ligand 8 | 4557 | 0.736 | 0.1324 | No |
| 36 | ADCY9 | NA | ADCY9 Entrez,  Source | adenylate cyclase 9 | 4606 | 0.724 | 0.1345 | No |
| 37 | PLCB3 | NA | PLCB3 Entrez,  Source | phospholipase C, beta 3 (phosphatidylinositol-specific) | 4800 | 0.683 | 0.1283 | No |
| 38 | HRAS | NA | HRAS Entrez,  Source | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 4840 | 0.674 | 0.1306 | No |
| 39 | CCR5 | NA | CCR5 Entrez,  Source | chemokine (C-C motif) receptor 5 | 4919 | 0.657 | 0.1306 | No |
| 40 | VAV2 | NA | VAV2 Entrez,  Source | vav 2 oncogene | 5030 | 0.636 | 0.1286 | No |
| 41 | CCL5 | NA | CCL5 Entrez,  Source | chemokine (C-C motif) ligand 5 | 5108 | 0.622 | 0.1284 | No |
| 42 | ARRB1 | NA | ARRB1 Entrez,  Source | arrestin, beta 1 | 5139 | 0.616 | 0.1309 | No |
| 43 | PF4 | NA | PF4 Entrez,  Source | platelet factor 4 (chemokine (C-X-C motif) ligand 4) | 5200 | 0.605 | 0.1315 | No |
| 44 | JAK3 | NA | JAK3 Entrez,  Source | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 5207 | 0.603 | 0.1352 | No |
| 45 | GNB5 | NA | GNB5 Entrez,  Source | guanine nucleotide binding protein (G protein), beta 5 | 5312 | 0.583 | 0.1333 | No |
| 46 | RASGRP2 | NA | RASGRP2 Entrez,  Source | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 5616 | 0.531 | 0.1198 | No |
| 47 | GNG3 | NA | GNG3 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 3 | 5738 | 0.510 | 0.1164 | No |
| 48 | GSK3A | NA | GSK3A Entrez,  Source | glycogen synthase kinase 3 alpha | 5789 | 0.501 | 0.1169 | No |
| 49 | GNB1 | NA | GNB1 Entrez,  Source | guanine nucleotide binding protein (G protein), beta polypeptide 1 | 6026 | 0.463 | 0.1067 | No |
| 50 | WASL | NA | WASL Entrez,  Source | Wiskott-Aldrich syndrome-like | 6105 | 0.449 | 0.1054 | No |
| 51 | AKT2 | NA | AKT2 Entrez,  Source | v-akt murine thymoma viral oncogene homolog 2 | 6498 | 0.385 | 0.0859 | No |
| 52 | GRK1 | NA | GRK1 Entrez,  Source | G protein-coupled receptor kinase 1 | 6522 | 0.382 | 0.0872 | No |
| 53 | CCR9 | NA | CCR9 Entrez,  Source | chemokine (C-C motif) receptor 9 | 6606 | 0.370 | 0.0850 | No |
| 54 | PRKX | NA | PRKX Entrez,  Source | protein kinase, X-linked | 6692 | 0.358 | 0.0826 | No |
| 55 | GNAI3 | NA | GNAI3 Entrez,  Source | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 | 6912 | 0.327 | 0.0725 | No |
| 56 | CCL17 | NA | CCL17 Entrez,  Source | chemokine (C-C motif) ligand 17 | 6936 | 0.324 | 0.0733 | No |
| 57 | CCL4 | NA | CCL4 Entrez,  Source | chemokine (C-C motif) ligand 4 | 7022 | 0.312 | 0.0706 | No |
| 58 | PREX1 | NA | PREX1 Entrez,  Source | - | 7083 | 0.305 | 0.0693 | No |
| 59 | CCL7 | NA | CCL7 Entrez,  Source | chemokine (C-C motif) ligand 7 | 7226 | 0.284 | 0.0632 | No |
| 60 | GNG5 | NA | GNG5 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 5 | 7429 | 0.259 | 0.0536 | No |
| 61 | ROCK2 | NA | ROCK2 Entrez,  Source | Rho-associated, coiled-coil containing protein kinase 2 | 7497 | 0.252 | 0.0515 | No |
| 62 | KRAS | NA | KRAS Entrez,  Source | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 7514 | 0.251 | 0.0523 | No |
| 63 | CCR8 | NA | CCR8 Entrez,  Source | chemokine (C-C motif) receptor 8 | 7555 | 0.248 | 0.0517 | No |
| 64 | PIK3CB | NA | PIK3CB Entrez,  Source | phosphoinositide-3-kinase, catalytic, beta polypeptide | 7635 | 0.240 | 0.0488 | No |
| 65 | ADCY4 | NA | ADCY4 Entrez,  Source | adenylate cyclase 4 | 7650 | 0.238 | 0.0496 | No |
| 66 | CCL1 | NA | CCL1 Entrez,  Source | chemokine (C-C motif) ligand 1 | 7894 | 0.215 | 0.0374 | No |
| 67 | ADCY6 | NA | ADCY6 Entrez,  Source | adenylate cyclase 6 | 7968 | 0.207 | 0.0347 | No |
| 68 | PF4V1 | NA | PF4V1 Entrez,  Source | platelet factor 4 variant 1 | 8049 | 0.196 | 0.0315 | No |
| 69 | WAS | NA | WAS Entrez,  Source | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 8082 | 0.191 | 0.0310 | No |
| 70 | PRKCB | NA | 8131 | 0.185 | 0.0295 | No | ||
| 71 | CXCL9 | NA | CXCL9 Entrez,  Source | chemokine (C-X-C motif) ligand 9 | 8156 | 0.181 | 0.0294 | No |
| 72 | ADCY1 | NA | ADCY1 Entrez,  Source | adenylate cyclase 1 (brain) | 8159 | 0.181 | 0.0305 | No |
| 73 | ROCK1 | NA | ROCK1 Entrez,  Source | Rho-associated, coiled-coil containing protein kinase 1 | 8463 | 0.156 | 0.0145 | No |
| 74 | CRKL | NA | CRKL Entrez,  Source | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 8717 | 0.130 | 0.0012 | No |
| 75 | XCR1 | NA | XCR1 Entrez,  Source | chemokine (C motif) receptor 1 | 8735 | 0.129 | 0.0011 | No |
| 76 | CCL20 | NA | CCL20 Entrez,  Source | chemokine (C-C motif) ligand 20 | 8746 | 0.127 | 0.0014 | No |
| 77 | PTK2 | NA | PTK2 Entrez,  Source | PTK2 protein tyrosine kinase 2 | 8777 | 0.123 | 0.0005 | No |
| 78 | ADCY2 | NA | ADCY2 Entrez,  Source | adenylate cyclase 2 (brain) | 8813 | 0.120 | -0.0007 | No |
| 79 | CXCR3 | NA | CXCR3 Entrez,  Source | chemokine (C-X-C motif) receptor 3 | 8957 | 0.103 | -0.0080 | No |
| 80 | CXCR6 | NA | CXCR6 Entrez,  Source | chemokine (C-X-C motif) receptor 6 | 9156 | 0.084 | -0.0186 | No |
| 81 | ELMO1 | NA | ELMO1 Entrez,  Source | engulfment and cell motility 1 | 9299 | 0.071 | -0.0261 | No |
| 82 | CCL24 | NA | CCL24 Entrez,  Source | chemokine (C-C motif) ligand 24 | 9357 | 0.066 | -0.0288 | No |
| 83 | CXCL12 | NA | CXCL12 Entrez,  Source | chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 9424 | 0.058 | -0.0322 | No |
| 84 | LYN | NA | LYN Entrez,  Source | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 9498 | 0.053 | -0.0359 | No |
| 85 | NFKBIA | NA | NFKBIA Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 9793 | 0.012 | -0.0523 | No |
| 86 | CHUK | NA | CHUK Entrez,  Source | conserved helix-loop-helix ubiquitous kinase | 9794 | 0.012 | -0.0523 | No |
| 87 | PIK3R5 | NA | PIK3R5 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 5, p101 | 9845 | 0.004 | -0.0550 | No |
| 88 | CRK | NA | CRK Entrez,  Source | v-crk sarcoma virus CT10 oncogene homolog (avian) | 9877 | 0.000 | -0.0568 | No |
| 89 | GNGT1 | NA | GNGT1 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 | 9894 | 0.000 | -0.0577 | No |
| 90 | CCL14 | NA | CCL14 Entrez,  Source | chemokine (C-C motif) ligand 14 | 10006 | 0.000 | -0.0639 | No |
| 91 | CCL18 | NA | CCL18 Entrez,  Source | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 10007 | 0.000 | -0.0639 | No |
| 92 | CCL4L2 | NA | CCL4L2 Entrez,  Source | chemokine (C-C motif) ligand 4-like 2 | 10030 | 0.000 | -0.0651 | No |
| 93 | CCL22 | NA | CCL22 Entrez,  Source | chemokine (C-C motif) ligand 22 | 10385 | -0.022 | -0.0849 | No |
| 94 | VAV3 | NA | VAV3 Entrez,  Source | vav 3 oncogene | 10409 | -0.025 | -0.0860 | No |
| 95 | GNG4 | NA | GNG4 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 4 | 10515 | -0.033 | -0.0917 | No |
| 96 | CCL27 | NA | CCL27 Entrez,  Source | chemokine (C-C motif) ligand 27 | 10532 | -0.036 | -0.0923 | No |
| 97 | CX3CL1 | NA | CX3CL1 Entrez,  Source | chemokine (C-X3-C motif) ligand 1 | 10558 | -0.036 | -0.0935 | No |
| 98 | CXCR2 | NA | 10598 | -0.042 | -0.0954 | No | ||
| 99 | HCK | NA | HCK Entrez,  Source | hemopoietic cell kinase | 10615 | -0.045 | -0.0960 | No |
| 100 | PRKACA | NA | PRKACA Entrez,  Source | protein kinase, cAMP-dependent, catalytic, alpha | 10652 | -0.045 | -0.0977 | No |
| 101 | ADCY7 | NA | ADCY7 Entrez,  Source | adenylate cyclase 7 | 10682 | -0.049 | -0.0990 | No |
| 102 | RELA | NA | RELA Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 10834 | -0.062 | -0.1071 | No |
| 103 | PRKACG | NA | PRKACG Entrez,  Source | protein kinase, cAMP-dependent, catalytic, gamma | 11122 | -0.095 | -0.1226 | No |
| 104 | CCL16 | NA | CCL16 Entrez,  Source | chemokine (C-C motif) ligand 16 | 11205 | -0.105 | -0.1265 | No |
| 105 | PARD3 | NA | PARD3 Entrez,  Source | par-3 partitioning defective 3 homolog (C. elegans) | 11281 | -0.112 | -0.1300 | No |
| 106 | CCR3 | NA | CCR3 Entrez,  Source | chemokine (C-C motif) receptor 3 | 11333 | -0.118 | -0.1320 | No |
| 107 | CXCL6 | NA | CXCL6 Entrez,  Source | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 11409 | -0.125 | -0.1354 | No |
| 108 | STAT3 | NA | STAT3 Entrez,  Source | signal transducer and activator of transcription 3 (acute-phase response factor) | 11455 | -0.129 | -0.1371 | No |
| 109 | CCL25 | NA | CCL25 Entrez,  Source | chemokine (C-C motif) ligand 25 | 11603 | -0.144 | -0.1444 | No |
| 110 | RAP1B | NA | RAP1B Entrez,  Source | RAP1B, member of RAS oncogene family | 11823 | -0.172 | -0.1555 | No |
| 111 | GNG10 | NA | GNG10 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 10 | 11940 | -0.184 | -0.1608 | No |
| 112 | GRK6 | NA | GRK6 Entrez,  Source | G protein-coupled receptor kinase 6 | 11943 | -0.185 | -0.1597 | No |
| 113 | CXCR1 | NA | 12007 | -0.191 | -0.1620 | No | ||
| 114 | GRB2 | NA | GRB2 Entrez,  Source | growth factor receptor-bound protein 2 | 12056 | -0.196 | -0.1634 | No |
| 115 | CCL3 | NA | CCL3 Entrez,  Source | chemokine (C-C motif) ligand 3 | 12099 | -0.201 | -0.1644 | No |
| 116 | NRAS | NA | NRAS Entrez,  Source | neuroblastoma RAS viral (v-ras) oncogene homolog | 12151 | -0.207 | -0.1659 | No |
| 117 | STAT5B | NA | STAT5B Entrez,  Source | signal transducer and activator of transcription 5B | 12285 | -0.224 | -0.1718 | No |
| 118 | RAC2 | NA | RAC2 Entrez,  Source | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 12326 | -0.230 | -0.1726 | No |
| 119 | XCL1 | NA | XCL1 Entrez,  Source | chemokine (C motif) ligand 1 | 12341 | -0.231 | -0.1718 | No |
| 120 | MAPK1 | NA | MAPK1 Entrez,  Source | mitogen-activated protein kinase 1 | 12360 | -0.233 | -0.1713 | No |
| 121 | PIK3R2 | NA | PIK3R2 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta) | 12508 | -0.252 | -0.1778 | No |
| 122 | PIK3CD | NA | PIK3CD Entrez,  Source | phosphoinositide-3-kinase, catalytic, delta polypeptide | 12596 | -0.262 | -0.1810 | No |
| 123 | FGR | NA | FGR Entrez,  Source | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 12675 | -0.273 | -0.1835 | No |
| 124 | CX3CR1 | NA | CX3CR1 Entrez,  Source | chemokine (C-X3-C motif) receptor 1 | 12701 | -0.275 | -0.1831 | No |
| 125 | CXCL13 | NA | CXCL13 Entrez,  Source | chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) | 12929 | -0.307 | -0.1938 | No |
| 126 | RAC1 | NA | RAC1 Entrez,  Source | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 13101 | -0.334 | -0.2012 | No |
| 127 | ADCY5 | NA | ADCY5 Entrez,  Source | adenylate cyclase 5 | 13236 | -0.354 | -0.2063 | No |
| 128 | CCR2 | NA | CCR2 Entrez,  Source | chemokine (C-C motif) receptor 2 | 13275 | -0.361 | -0.2061 | No |
| 129 | CCL15 | NA | CCL15 Entrez,  Source | chemokine (C-C motif) ligand 15 | 13276 | -0.362 | -0.2037 | No |
| 130 | PPBP | NA | PPBP Entrez,  Source | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 13324 | -0.371 | -0.2038 | No |
| 131 | RAF1 | NA | RAF1 Entrez,  Source | v-raf-1 murine leukemia viral oncogene homolog 1 | 13760 | -0.446 | -0.2253 | No |
| 132 | RAP1A | NA | RAP1A Entrez,  Source | RAP1A, member of RAS oncogene family | 13883 | -0.468 | -0.2290 | No |
| 133 | GNB2 | NA | GNB2 Entrez,  Source | guanine nucleotide binding protein (G protein), beta polypeptide 2 | 13939 | -0.478 | -0.2289 | No |
| 134 | GRK7 | NA | GRK7 Entrez,  Source | G protein-coupled receptor kinase 7 | 14137 | -0.517 | -0.2365 | No |
| 135 | ADCY8 | NA | ADCY8 Entrez,  Source | adenylate cyclase 8 (brain) | 14346 | -0.562 | -0.2445 | No |
| 136 | CCL2 | NA | CCL2 Entrez,  Source | chemokine (C-C motif) ligand 2 | 14501 | -0.592 | -0.2492 | No |
| 137 | PLCB1 | NA | PLCB1 Entrez,  Source | phospholipase C, beta 1 (phosphoinositide-specific) | 14805 | -0.670 | -0.2617 | No |
| 138 | AKT3 | NA | AKT3 Entrez,  Source | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 14929 | -0.703 | -0.2640 | No |
| 139 | PAK1 | NA | PAK1 Entrez,  Source | p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) | 15023 | -0.727 | -0.2643 | No |
| 140 | CCR4 | NA | CCR4 Entrez,  Source | chemokine (C-C motif) receptor 4 | 15125 | -0.752 | -0.2650 | Yes |
| 141 | BRAF | NA | BRAF Entrez,  Source | v-raf murine sarcoma viral oncogene homolog B1 | 15145 | -0.758 | -0.2610 | Yes |
| 142 | PXN | NA | PXN Entrez,  Source | paxillin | 15311 | -0.807 | -0.2649 | Yes |
| 143 | GNG12 | NA | GNG12 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 12 | 15316 | -0.810 | -0.2597 | Yes |
| 144 | AKT1 | NA | AKT1 Entrez,  Source | v-akt murine thymoma viral oncogene homolog 1 | 15339 | -0.816 | -0.2555 | Yes |
| 145 | NFKB1 | NA | NFKB1 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 15399 | -0.833 | -0.2533 | Yes |
| 146 | FOXO3 | NA | 15433 | -0.842 | -0.2495 | Yes | ||
| 147 | PRKACB | NA | PRKACB Entrez,  Source | protein kinase, cAMP-dependent, catalytic, beta | 15440 | -0.844 | -0.2442 | Yes |
| 148 | CCR1 | NA | CCR1 Entrez,  Source | chemokine (C-C motif) receptor 1 | 15496 | -0.861 | -0.2416 | Yes |
| 149 | RHOA | NA | RHOA Entrez,  Source | ras homolog gene family, member A | 15597 | -0.894 | -0.2413 | Yes |
| 150 | CXCL3 | NA | CXCL3 Entrez,  Source | chemokine (C-X-C motif) ligand 3 | 15611 | -0.898 | -0.2360 | Yes |
| 151 | GNAI2 | NA | GNAI2 Entrez,  Source | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 15665 | -0.914 | -0.2329 | Yes |
| 152 | GSK3B | NA | GSK3B Entrez,  Source | glycogen synthase kinase 3 beta | 15818 | -0.977 | -0.2349 | Yes |
| 153 | ADCY3 | NA | ADCY3 Entrez,  Source | adenylate cyclase 3 | 16173 | -1.126 | -0.2473 | Yes |
| 154 | MAPK3 | NA | MAPK3 Entrez,  Source | mitogen-activated protein kinase 3 | 16431 | -1.263 | -0.2533 | Yes |
| 155 | MAP2K1 | NA | MAP2K1 Entrez,  Source | mitogen-activated protein kinase kinase 1 | 16504 | -1.300 | -0.2487 | Yes |
| 156 | PTK2B | NA | PTK2B Entrez,  Source | PTK2B protein tyrosine kinase 2 beta | 16569 | -1.348 | -0.2433 | Yes |
| 157 | TIAM2 | NA | TIAM2 Entrez,  Source | T-cell lymphoma invasion and metastasis 2 | 16639 | -1.387 | -0.2379 | Yes |
| 158 | GRK5 | NA | GRK5 Entrez,  Source | G protein-coupled receptor kinase 5 | 16762 | -1.478 | -0.2349 | Yes |
| 159 | CCR10 | NA | CCR10 Entrez,  Source | chemokine (C-C motif) receptor 10 | 16763 | -1.478 | -0.2251 | Yes |
| 160 | SHC1 | NA | SHC1 Entrez,  Source | SHC (Src homology 2 domain containing) transforming protein 1 | 17055 | -1.738 | -0.2298 | Yes |
| 161 | GNG11 | NA | GNG11 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 11 | 17066 | -1.755 | -0.2187 | Yes |
| 162 | GNG7 | NA | GNG7 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 7 | 17191 | -1.902 | -0.2130 | Yes |
| 163 | PRKCD | NA | PRKCD Entrez,  Source | protein kinase C, delta | 17310 | -2.062 | -0.2059 | Yes |
| 164 | PRKCZ | NA | PRKCZ Entrez,  Source | protein kinase C, zeta | 17333 | -2.098 | -0.1931 | Yes |
| 165 | CSK | NA | CSK Entrez,  Source | c-src tyrosine kinase | 17372 | -2.166 | -0.1808 | Yes |
| 166 | CXCL5 | NA | CXCL5 Entrez,  Source | chemokine (C-X-C motif) ligand 5 | 17596 | -2.718 | -0.1753 | Yes |
| 167 | GNB3 | NA | GNB3 Entrez,  Source | guanine nucleotide binding protein (G protein), beta polypeptide 3 | 17620 | -2.776 | -0.1580 | Yes |
| 168 | TIAM1 | NA | TIAM1 Entrez,  Source | T-cell lymphoma invasion and metastasis 1 | 17655 | -2.958 | -0.1402 | Yes |
| 169 | CXCL1 | NA | CXCL1 Entrez,  Source | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 17669 | -3.027 | -0.1208 | Yes |
| 170 | PLCB2 | NA | PLCB2 Entrez,  Source | phospholipase C, beta 2 | 17672 | -3.047 | -0.1006 | Yes |
| 171 | GNG2 | NA | GNG2 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma 2 | 17811 | -3.820 | -0.0829 | Yes |
| 172 | ITK | NA | ITK Entrez,  Source | IL2-inducible T-cell kinase | 17842 | -4.008 | -0.0579 | Yes |
| 173 | PIK3CG | NA | PIK3CG Entrez,  Source | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 17957 | -4.885 | -0.0317 | Yes |
| 174 | GNGT2 | NA | GNGT2 Entrez,  Source | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 | 17971 | -4.948 | 0.0005 | Yes |

